Skip to main content
PathAI logo

PathAI

Updated Mar 24, 2026

PathAI's full profile: funding, valuation, competitors, and the people behind the company.

🇺🇸United StatesSeries CAI Healthcare

Out of 100

🇺🇸

HQ

United States

🗓

Founded

2016

💰

Raised

$490M

🏷️

Stage

Series C

👥

Team

300

PathAI is an AI healthcare company founded in 2016 that develops digital pathology solutions and AI-powered diagnostic tools for pathology labs and healthcare institutions. The company specializes in machine learning algorithms designed to assist pathologists in analyzing tissue samples and identifying diseases, particularly cancer. PathAI's core technology platform applies deep learning and

Is this your company? Claim it →

Key Facts

  • PathAI has raised a total of $490M in disclosed funding across 3 funding rounds.
  • PathAI was founded in 2016 by Andy Beck and is headquartered in United States.
  • PathAI employs approximately 300 people.
  • PathAI operates in the AI Healthcare category and is currently at the Series C stage.
  • PathAI has an Awaira Score of 62/100, ranking it among the tracked AI companies on Awaira.
  • PathAI's most recent funding round was a Series C of $165M closed in January 2021.

Source: Awaira · Updated Mar 24, 2026

N/A

Post-money

$490M

All rounds

62/100

2016

300 employees

Strengths

Strong Awaira Score of 62/100

Growing team of 300 employees

Late-stage with proven business model

Considerations

!

Valuation not publicly disclosed

Analysis based on publicly available data. Not investment advice.

3

Total Rounds

$85M

Avg Round Size

3.1yr

Funding Span

PathAI raised 3 rounds over 3.1 years, averaging $85M per round — a pace of roughly one round every 12 months.

⚠️ ESTIMATE
💵Est. Annual Revenue
$20M–$100M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does PathAI stack up against competitors?

MetricPathAIButterfly NetworkTempusAlan
Awaira Score62/10085/10084/10083/100
Total Raised$490M$370M$1.05B$750M
ValuationN/A$957M$8.1B$5.83B
StageSeries CPublicPublicSeries D
Founded2016201120152016
Employees300500-10002500500-1000
Country🇺🇸🇺🇸🇺🇸🇫🇷
A

Andy Beck

Founder & CEO

View founder profile →
StageSeries C
Employees300
Country🇺🇸 United States
Connect
Inactive
3 rounds
Series CLatest

$165M

Jan 2021

Series B

Khosla Ventures, Mayo Clinic

$75M

Jan 2019

Series A

$15M

Jan 2018

Frequently Asked Questions

What is PathAI's valuation?
A confirmed valuation hasn't been made public. This is common for Series C-stage companies in the AI Healthcare sector.
Who invested in PathAI?
Khosla Ventures, Mayo Clinic are among the backers. Together, they've contributed to the company's growth in the AI Healthcare sector.
When did PathAI last raise funding?
The most recent round was a Series C of $165M, closed in January 2021.
How many employees does PathAI have?
The team is roughly 300 people, headquartered in United States.
What does PathAI do?
PathAI is an AI healthcare company founded in 2016 that develops digital pathology solutions and AI-powered diagnostic tools for pathology labs and healthcare institutions. The company specializes in machine learning algorithms designed to assist pathologists in analyzing tissue samples and identifying diseases, particularly cancer.
Who founded PathAI?
The company was started by Andy Beck in 2016 in United States. Andy Beck serves as Founder & CEO.
Is PathAI profitable?
Profitability data isn't available in public filings. The company has raised $490M in total funding and operates at the Series C stage.
Where is PathAI headquartered?
The headquarters sit in United States 🇺🇸 and was established in 2016. It competes in the AI Healthcare sector.
⚔️

Compare PathAI

See how PathAI stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →